vs
Side-by-side financial comparison of Laird Superfood, Inc. (LSF) and Sunshine Biopharma Inc. (SBFM). Click either name above to swap in a different company.
Laird Superfood, Inc. is the larger business by last-quarter revenue ($13.3M vs $8.6M, roughly 1.6× Sunshine Biopharma Inc.). Laird Superfood, Inc. runs the higher net margin — -13.2% vs -25.0%, a 11.8% gap on every dollar of revenue. On growth, Laird Superfood, Inc. posted the faster year-over-year revenue change (15.0% vs -10.6%). Over the past eight quarters, Laird Superfood, Inc.'s revenue compounded faster (16.1% CAGR vs 6.6%).
Laird Superfood, Inc. develops, manufactures and sells a portfolio of plant-based functional superfood products, including premium coffee creamers, hydration blends, nutritional supplements, and plant-powered snacks. It serves health-conscious consumers through direct-to-consumer e-commerce platforms and offline retail partners, mainly operating in the North American market with a focus on sustainably sourced clean ingredients.
Sunshine Biopharma Inc. is a clinical-stage biopharmaceutical company focused on researching, developing and commercializing innovative therapies for oncology, neurodegenerative disorders and infectious diseases. It targets unmet medical needs across global markets, with a pipeline of targeted therapeutic candidates designed to improve patient treatment outcomes.
LSF vs SBFM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $13.3M | $8.6M |
| Net Profit | $-1.8M | $-2.1M |
| Gross Margin | 34.1% | 35.3% |
| Operating Margin | -13.5% | -20.9% |
| Net Margin | -13.2% | -25.0% |
| Revenue YoY | 15.0% | -10.6% |
| Net Profit YoY | -341.4% | 0.8% |
| EPS (diluted) | — | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $13.3M | $8.6M | ||
| Q3 25 | $12.9M | $9.4M | ||
| Q2 25 | $12.0M | $9.4M | ||
| Q1 25 | $11.7M | $8.9M | ||
| Q4 24 | $11.6M | $9.6M | ||
| Q3 24 | $11.8M | $8.4M | ||
| Q2 24 | $10.0M | $9.3M | ||
| Q1 24 | $9.9M | $7.5M |
| Q4 25 | $-1.8M | $-2.1M | ||
| Q3 25 | $-975.1K | $-883.8K | ||
| Q2 25 | $-362.2K | $-1.8M | ||
| Q1 25 | $-156.2K | $-1.2M | ||
| Q4 24 | $-398.4K | $-2.2M | ||
| Q3 24 | $-166.1K | $-1.2M | ||
| Q2 24 | $-239.1K | $-494.3K | ||
| Q1 24 | $-1.0M | $-1.3M |
| Q4 25 | 34.1% | 35.3% | ||
| Q3 25 | 36.5% | 32.6% | ||
| Q2 25 | 39.9% | 36.4% | ||
| Q1 25 | 41.9% | 30.7% | ||
| Q4 24 | 38.6% | 32.2% | ||
| Q3 24 | 43.0% | 34.0% | ||
| Q2 24 | 41.8% | 25.3% | ||
| Q1 24 | 40.0% | 31.2% |
| Q4 25 | -13.5% | -20.9% | ||
| Q3 25 | -7.7% | -11.5% | ||
| Q2 25 | -3.3% | -21.8% | ||
| Q1 25 | -1.9% | -14.6% | ||
| Q4 24 | -4.1% | -21.7% | ||
| Q3 24 | -2.3% | -13.1% | ||
| Q2 24 | -3.4% | -13.6% | ||
| Q1 24 | -11.0% | -17.9% |
| Q4 25 | -13.2% | -25.0% | ||
| Q3 25 | -7.6% | -9.4% | ||
| Q2 25 | -3.0% | -18.8% | ||
| Q1 25 | -1.3% | -13.3% | ||
| Q4 24 | -3.4% | -22.5% | ||
| Q3 24 | -1.4% | -14.2% | ||
| Q2 24 | -2.4% | -5.3% | ||
| Q1 24 | -10.3% | -17.0% |
| Q4 25 | — | — | ||
| Q3 25 | — | $-0.54 | ||
| Q2 25 | — | $-0.82 | ||
| Q1 25 | — | $-0.44 | ||
| Q4 24 | — | $49.77 | ||
| Q3 24 | — | $-11.61 | ||
| Q2 24 | — | $-43.48 | ||
| Q1 24 | — | $-2.00 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $5.1M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $11.5M | $23.0M |
| Total Assets | $19.2M | $30.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $5.1M | — | ||
| Q3 25 | $5.1M | — | ||
| Q2 25 | $3.9M | — | ||
| Q1 25 | $7.0M | — | ||
| Q4 24 | $8.3M | — | ||
| Q3 24 | $7.9M | — | ||
| Q2 24 | $7.6M | — | ||
| Q1 24 | $7.1M | — |
| Q4 25 | $11.5M | $23.0M | ||
| Q3 25 | $12.8M | $24.2M | ||
| Q2 25 | $13.4M | $25.7M | ||
| Q1 25 | $13.3M | $22.7M | ||
| Q4 24 | $13.2M | $23.5M | ||
| Q3 24 | $13.1M | $25.0M | ||
| Q2 24 | $12.6M | $23.5M | ||
| Q1 24 | $12.7M | $24.8M |
| Q4 25 | $19.2M | $30.1M | ||
| Q3 25 | $18.9M | $31.5M | ||
| Q2 25 | $20.4M | $32.0M | ||
| Q1 25 | $21.5M | $29.2M | ||
| Q4 24 | $19.3M | $30.6M | ||
| Q3 24 | $18.8M | $30.1M | ||
| Q2 24 | $18.0M | $29.3M | ||
| Q1 24 | $17.6M | $31.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $68.4K | $-1.6M |
| Free Cash FlowOCF − Capex | — | $-1.6M |
| FCF MarginFCF / Revenue | — | -18.9% |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-5.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $68.4K | $-1.6M | ||
| Q3 25 | $1.2M | $-727.8K | ||
| Q2 25 | $-2.8M | $-1.3M | ||
| Q1 25 | $-1.3M | $-1.7M | ||
| Q4 24 | $339.2K | $-3.4M | ||
| Q3 24 | $305.8K | $-1.4M | ||
| Q2 24 | $642.7K | $-4.6M | ||
| Q1 24 | $-422.3K | $-3.2M |
| Q4 25 | — | $-1.6M | ||
| Q3 25 | — | $-735.8K | ||
| Q2 25 | — | $-1.4M | ||
| Q1 25 | — | $-1.7M | ||
| Q4 24 | — | $-3.5M | ||
| Q3 24 | — | $-1.9M | ||
| Q2 24 | — | $-5.6M | ||
| Q1 24 | — | $-3.2M |
| Q4 25 | — | -18.9% | ||
| Q3 25 | — | -7.8% | ||
| Q2 25 | — | -15.2% | ||
| Q1 25 | — | -19.3% | ||
| Q4 24 | — | -36.6% | ||
| Q3 24 | — | -22.2% | ||
| Q2 24 | — | -59.7% | ||
| Q1 24 | — | -43.1% |
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.1% | ||
| Q2 25 | — | 1.7% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 1.1% | ||
| Q3 24 | — | 6.1% | ||
| Q2 24 | — | 10.5% | ||
| Q1 24 | — | 0.8% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LSF
| Wholesale | $7.0M | 52% |
| Coffee Tea And Hot Chocolate Products | $4.4M | 33% |
| Hydration And Beverage Enhancing Supplements | $1.6M | 12% |
| Other | $352.6K | 3% |
SBFM
Segment breakdown not available.
